QMIS LLC researches and develops MRI-based quantitative and automated tools for improved diagnosis of prostate cancer (PCa). The firm's primary product is MRViPro (MR Virtual Pathology of the Prostate) which provides data based on compartmental analysis of Hybrid-Multidimensional MRI. The product is an image processing software that analyzes data from HM-MRI, a 2D matrix of diffusion-weighted and T2-weighted MRI data. The solution provides Radiologists and researchers with accurate virtual pathology, which is vital for accurate Prostate cancer diagnosis.
